DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Kubitza D, Becka M, Voith B. et al.
Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59–7939, an oral, direct factor Xa inhibitor.
Clin Pharmacol Ther 2005;
78: 412-421.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.